Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aqw051
1. 669770-29-0
2. Aqw051
3. Jqh481r778
4. (3r)-3-{[6-(4-methylphenyl)pyridin-3-yl]oxy}-1-azabicyclo[2.2.2]octane
5. (3r)-3-((6-(4-methylphenyl)pyridin-3-yl)oxy)-1-azabicyclo(2.2.2)octane
6. Refchem:113617
7. Vqw-765
8. 1-azabicyclo[2.2.2]octane, 3-[[6-(4-methylphenyl)-3-pyridinyl]oxy]-, (3r)-
9. Mfcd28502153
10. Chembl4532388
11. (r)-3-((6-(p-tolyl)pyridin-3-yl)oxy)quinuclidine
12. (3r)-3-[6-(4-methylphenyl)pyridin-3-yl]oxy-1-azabicyclo[2.2.2]octane
13. 1-azabicyclo(2.2.2)octane, 3-((6-(4-methylphenyl)-3-pyridinyl)oxy)-, (3r)-
14. Aqw 051
15. Npdltezxgwrmlq-ibgzpjmesa-n
16. Nvp-aqw051
17. Unii-jqh481r778
18. Gtpl7371
19. Orb1701184
20. Schembl1459285
21. Vqw765
22. Vqw 765
23. Glxc-15846
24. Bdbm50520725
25. Akos030628482
26. As-35273
27. Da-50661
28. Hy-19490
29. Cs-0015589
30. (3r)-3-[[6-(p-tolyl)-3-pyridyl]oxy]quinuclidine
31. Q27074487
32. (r)-3-(6-p-tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane
| Molecular Weight | 294.4 g/mol |
|---|---|
| Molecular Formula | C19H22N2O |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 25.4 |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 358 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
81
PharmaCompass offers a list of VQW-765 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right VQW-765 manufacturer or VQW-765 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred VQW-765 manufacturer or VQW-765 supplier.
A VQW 765 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of VQW 765, including repackagers and relabelers. The FDA regulates VQW 765 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. VQW 765 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A VQW 765 supplier is an individual or a company that provides VQW 765 active pharmaceutical ingredient (API) or VQW 765 finished formulations upon request. The VQW 765 suppliers may include VQW 765 API manufacturers, exporters, distributors and traders.
VQW 765 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of VQW 765 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right VQW 765 GMP manufacturer or VQW 765 GMP API supplier for your needs.
A VQW 765 CoA (Certificate of Analysis) is a formal document that attests to VQW 765's compliance with VQW 765 specifications and serves as a tool for batch-level quality control.
VQW 765 CoA mostly includes findings from lab analyses of a specific batch. For each VQW 765 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
VQW 765 may be tested according to a variety of international standards, such as European Pharmacopoeia (VQW 765 EP), VQW 765 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (VQW 765 USP).
